Kids’ COVID More Dangerous When Co-Infected With RSV, Colds
WEDNESDAY, Jan. 18, 2023 (HealthDay News) — As colds, flu and COVID continue to circulate this winter, a new U.S. government study finds that young children infected with COVID plus a second virus tend to become sicker.While severe COVID is rare amon…
Learn MoreConvalescent COVID-19 Plasma Beneficial for Immunocompromised
TUESDAY, Jan. 17, 2023 (HealthDay News) — Transfusion of convalescent COVID-19 plasma is associated with a reduction in mortality for immunocompromised patients, according to a systematic review published online Jan. 12 in JAMA Network Open.Jonathon …
Learn MoreGetting COVID in Pregnancy Greatly Raises a Woman’s Odds for Death
TUESDAY, Jan. 17, 2023 (HealthDay News) — COVID-19 infection in pregnancy raises a woman’s risk of death sevenfold and significantly elevates her odds for needing intensive care, a new study finds.Getting the virus during pregnancy also ups the likel…
Learn MoreHoliday Gatherings Didn’t Trigger Spike in Respiratory Illnesses: CDC
MONDAY, Jan. 16, 2023 (HealthDay News) – Going into the holiday season, many public health experts feared a “tripledemic” of flu, COVID-19 and RSV cases.New government data now shows that didn’t happen.Reports of flu-like illness are down for the sixt…
Learn More¿COVID prolongada tras una infección leve? Desaparece en un año
JUEVES, 12 de enero de 2023 (HealthDay News) — Un nuevo estudio de gran tamaño ofrece noticias tranquilizadoras a las personas que se enfrentan a los síntomas de COVID prolongada, como los problemas para respirar, las lagunas mentales y la pérdida de…
Learn MoreMost Long COVID Resolves Within One Year for Mild Infections
FRIDAY, Jan. 13, 2023 (HealthDay News) — Most long COVID symptoms will resolve following mild infection within a year, according to an Israeli study published online Jan. 11 in The BMJ.Barak Mizrahi, from KI Research Institute in Kfar Malal, Israel, …
Learn MoreFluvoxamine Does Not Improve Time to Sustained Recovery in Mild COVID-19
THURSDAY, Jan. 12, 2023 (HealthDay News) — For patients with mild-to-moderate COVID-19, treatment with fluvoxamine does not improve time to sustained recovery versus placebo, according to a study published online Jan. 12 in Journal of the American Me…
Learn MoreAumenta la aceptación global de las vacunas contra la COVID-19
MIÉRCOLES, 11 de enero de 2023 (HealthDay News) — Aunque la aceptación de las vacunas contra la COVID-19 aumento en todo el mundo entre 2021 y 2022, persisten unas grandes brechas, según una investigación reciente.Los equipos, del Instituto de Salud …
Learn More